Literature DB >> 26528887

Interaction of ApoE3 and ApoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory.

Fabrizio Biundo1, Keita Ishiwari1, Dolores Del Prete1, Luciano D'Adamio2.   

Abstract

Mutations in Amyloid β Precursor Protein (APP) and in genes that regulate APP processing--such as PSEN1/2 and ITM2b/BRI2--cause familial dementia, such Familial Alzheimer disease (FAD), Familial Danish (FDD) and British (FBD) dementias. The ApoE gene is the major genetic risk factor for sporadic AD. Three major variants of ApoE exist in humans (ApoE2, ApoE3, and ApoE4), with the ApoE4 allele being strongly associated with AD. ITM2b/BRI2 is also a candidate regulatory node genes predicted to mediate the common patterns of gene expression shared by healthy ApoE4 carriers and late-onset AD patients not carrying ApoE4. This evidence provides a direct link between ITM2b/BRI2 and ApoE4. To test whether ApoE4 and pathogenic ITM2b/BRI2 interact to modulate learning and memory, we crossed a mouse carrying the ITM2b/BRI2 mutations that causes FDD knocked-in the endogenous mouse Itm2b/Bri2 gene (FDDKI mice) with human ApoE3 and ApoE4 targeted replacement mice. The resultant ApoE3, FDDKI/ApoE3, ApoE4, FDDKI/ApoE4 male mice were assessed longitudinally for learning and memory at 4, 6, 12, and 16-17 months of age. The results showed that ApoE4-carrying mice displayed spatial working/short-term memory deficits relative to ApoE3-carrying mice starting in early middle age, while long-term spatial memory of ApoE4 mice was not adversely affected even at 16-17 months, and that the FDD mutation impaired working/short-term spatial memory in ApoE3-carrying mice and produced impaired long-term spatial memory in ApoE4-carrying mice in middle age. The present results suggest that the FDD mutation may differentially affect learning and memory in ApoE4 carriers and non-carriers.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; ApoE; BRI2; Familial Danish dementia

Mesh:

Substances:

Year:  2015        PMID: 26528887      PMCID: PMC4900468          DOI: 10.1016/j.nlm.2015.10.009

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  65 in total

Review 1.  Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.

Authors:  Dennis J Selkoe
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation.

Authors:  T Revesz; J L Holton; B Doshi; B H Anderton; F Scaravilli; G T Plant
Journal:  Acta Neuropathol       Date:  1999-02       Impact factor: 17.088

Review 3.  Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.

Authors:  Sheila Crean; Alex Ward; Catherine J Mercaldi; Jenna M Collins; Michael N Cook; Nicole L Baker; H Michael Arrighi
Journal:  Dement Geriatr Cogn Disord       Date:  2010-12-01       Impact factor: 2.959

4.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

5.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

Authors:  R Vidal; T Revesz; A Rostagno; E Kim; J L Holton; T Bek; M Bojsen-Møller; H Braendgaard; G Plant; J Ghiso; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

6.  Increased AβPP processing in familial Danish dementia patients.

Authors:  Shuji Matsuda; Robert Tamayev; Luciano D'Adamio
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Roles of A beta and carboxyl terminal peptide fragments of amyloid precursor protein in Alzheimer disease.

Authors:  Y H Suh; H S Kim; J P Lee; C H Park; S J Jeong; S S Kim; J C Rah; J H Seo; S S Kim
Journal:  J Neural Transm Suppl       Date:  2000

8.  Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults.

Authors:  J D Flory; S B Manuck; R E Ferrell; C M Ryan; M F Muldoon
Journal:  Am J Med Genet       Date:  2000-12-04

Review 9.  The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.

Authors:  U Beffert; M Danik; P Krzywkowski; C Ramassamy; F Berrada; J Poirier
Journal:  Brain Res Brain Res Rev       Date:  1998-07

10.  Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.

Authors:  H L West; G W Rebeck; B T Hyman
Journal:  Neurosci Lett       Date:  1994-07-04       Impact factor: 3.046

View more
  4 in total

1.  APOE influences working memory in non-demented elderly through an interaction with SPON1 rs2618516.

Authors:  Zhen Liu; Xiangwei Dai; Wuhai Tao; Huilan Liu; He Li; Caishui Yang; Junying Zhang; Xin Li; Yaojing Chen; Chao Ma; Jing Pei; Haohao Mao; Kewei Chen; Zhanjun Zhang
Journal:  Hum Brain Mapp       Date:  2018-03-24       Impact factor: 5.038

2.  Abolishing Tau cleavage by caspases at Aspartate421 causes memory/synaptic plasticity deficits and pre-pathological Tau alterations.

Authors:  F Biundo; C d'Abramo; M D Tambini; H Zhang; D Del Prete; F Vitale; L Giliberto; O Arancio; L D'Adamio
Journal:  Transl Psychiatry       Date:  2017-08-08       Impact factor: 6.222

3.  Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function.

Authors:  Adam L Orr; Chaeyoung Kim; David Jimenez-Morales; Billy W Newton; Jeffrey R Johnson; Nevan J Krogan; Danielle L Swaney; Robert W Mahley
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  A role for tau in learning, memory and synaptic plasticity.

Authors:  Fabrizio Biundo; Dolores Del Prete; Hong Zhang; Ottavio Arancio; Luciano D'Adamio
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.